Curis, Inc. (CRIS) Financials
CRIS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 77.3 million | 57.6 million |
2023-09-30 | 90.0 million | 60.4 million |
2023-06-30 | 84.3 million | 58.1 million |
2023-03-31 | 94.5 million | 58.0 million |
CRIS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -10.2 million | 1.5 million |
2023-09-30 | -8.2 million | 1.6 million |
2023-06-30 | -7.9 million | 1.4 million |
2023-03-31 | -12.2 million | 1.4 million |
CRIS Net Income
No data available :(
CRIS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 56.3 million | - | 2.8 million |
2023-09-30 | 68.5 million | - | 3.1 million |
2023-06-30 | 63.5 million | - | 3.4 million |
2023-03-31 | 71.8 million | - | 3.7 million |
CRIS Shares Outstanding
CRIS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 10.0 million | 4.9 million | - |
2023-09-30 | - | 10.4 million | 4.8 million | - |
2023-06-30 | - | 10.0 million | 4.2 million | - |
2023-03-31 | - | 9.1 million | 4.8 million | - |
CRIS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 2.7 million | 158000 |
2023-09-30 | 2.8 million | 60000 |
2023-06-30 | 2.2 million | 74000 |
2023-03-31 | 2.3 million | 24000 |
CRIS
Price: $16.10
52 week price:
Earnings Per Share: -8.96 USD
P/E Ratio: -0.91
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 479800
Ebitda: -14.2 millionMarket Capitalization: 96.4 million